Abuja190 Nigerians died of Lassa fever in 2026 as the fatality rate reached 25.2%, up from 19.1% last year.
Nigeria’s disease-control agency tied the rise to delayed hospital presentation; ribavirin is effective when given early.
84% of cases concentrate in 5 states; the agency said earlier referrals are the primary lever.
Sources: Premium Times Nigeria
THE RESERVOIR
Lassa is carried by Mastomys natalensis, the multimammate rat — one of West Africa's most abundant rodents. It sheds virus in urine and droppings, contaminating stored food and household surfaces. Unlike Ebola, the reservoir lives inside human dwellings, which is why Lassa never goes away between outbreaks.
WHAT CFR ACTUALLY MEASURES
Case fatality rate is deaths divided by confirmed cases. A rising CFR rarely means the virus got more lethal — it usually means mild cases are no longer being counted. When only the sickest patients reach a hospital and get tested, the denominator collapses and the ratio climbs.
THE RIBAVIRIN WINDOW
Ribavirin, a 1970s broad-spectrum antiviral, cuts Lassa mortality from roughly 50% to under 5% — but only if started within the first six days of symptoms. After that the drug barely outperforms supportive care. The treatment exists; the bottleneck is reaching it in time.
THE GEOGRAPHY
Lassa is endemic across the West African forest-savanna belt, but Nigeria's case load concentrates in Edo, Ondo, Bauchi, Taraba and Ebonyi — the same five states year after year. The pattern tracks rodent ecology and housing density, not state borders.
THE 1969 DISCOVERY
The virus was identified after a missionary nurse died in the town of Lassa, Borno State, in 1969. Two of the three CDC virologists who isolated it also fell ill; one died. Lassa was one of the first pathogens to force the design of modern BSL-4 containment protocols.
WHY EARLIER REFERRAL IS THE LEVER
Lassa's early symptoms — fever, headache, malaise — are indistinguishable from malaria, which is what most Nigerian clinicians treat first. By the time bleeding or hearing loss appears, the ribavirin window has closed. The fix is not a new drug; it is a referral protocol that tests for Lassa before the malaria treatment fails.